Home
Clinic
Multiple Sclerosis
Parkinson’s Disease
Alzheimer’s Disease
Neuromuscular
Glioblastoma Multiforme
Stroke Care and Recovery
Services
Team
MS Protocols
Clinical Trials
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Parkinson Disease (PD)
Multifocal Motor Neuropathy (MMN)
Amyotrophic lateral sclerosis (ALS)
Alzheimer’s Disease (AD)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Glioblastoma Multiforme (GBM)
Neuro Rehabilitation
rTMS
Infusion Clinic
Contact
English
Home
Clinic
Multiple Sclerosis
Parkinson’s Disease
Alzheimer’s Disease
Neuromuscular
Glioblastoma Multiforme
Stroke Care and Recovery
Services
Team
MS Protocols
Clinical Trials
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Parkinson Disease (PD)
Multifocal Motor Neuropathy (MMN)
Amyotrophic lateral sclerosis (ALS)
Alzheimer’s Disease (AD)
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Glioblastoma Multiforme (GBM)
Neuro Rehabilitation
rTMS
Infusion Clinic
Contact
English
Fampyra /Ampyra
A-aminopyridine
THERAPY
Coverage
Protocols
Product Monograph
Coverage
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland & Labrador
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Northwest Territories
Protocols
Before Initiation of Therapy :
CBC, creatinine, TSH, Liver enzyme, Total Bilirubin, Na, K, urinalysis, creatinine clairance
Pregnancy test and counseling with regards to contraception
T25FW at day 0 and 21st
Monitoring During Therapy :
CBC, creatinine clairance, q.6 Months
Product Monograph
View Now
